Although high-level p16 expression normally halts cellular proliferation by inhibiting the ability of cyclin D/CDK4/6 complexes to phosphorylate and inactivate pRb [33], human melanomas and DLBCLs can escape the effect of p16 by inducing cyclin E expression [56,57]. The gene discussed is CDK4; the disease is melanoma.